Adjuvant immunotherapy of dendritic cells and cytokine-induced killer cells is safe and enhances chemotherapy efficacy for multiple myeloma in China: a meta-analysis of clinical trials
Yan Wang,1 Benji Lv,2 Ke Li,3 Anqi Zhang,3 Hong Liu3 1Department of Clinical Laboratory, 2Department of Blood Transfusion, 3Department of Central Laboratory, Liaocheng People’s Hospital, Liaocheng Clinical School of Taishan Medical University, Liaocheng, Shandong Province, China Objective:...
Saved in:
Main Authors: | Wang Y (Author), Lv BJ (Author), Li K (Author), Zhang AQ (Author), Liu H (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2017-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rescue SLAMF7 activity in exhausted natural killer cells: Novel challenges in the immunotherapy of multiple myeloma
by: Alessandra Zingoni, et al.
Published: (2022) -
Efficacy of cytokine-induced killer cell infusion as an adjuvant immunotherapy for hepatocellular carcinoma: a systematic review and meta-analysis
by: Yu R, et al.
Published: (2017) -
Pomalidomide enhances the maturation of dendritic cells derived from healthy donors and multiple myeloma patients
by: Xi Wang, et al.
Published: (2022) -
Cytokine-induced killer cell treatment is superior to chemotherapy alone in esophageal cancer
by: Jiayang Sun, et al.
Published: (2023) -
Cell-based immunotherapy with cytokine-induced killer (CIK) cells: From preparation and testing to clinical application
by: Yiming Meng, et al.
Published: (2017)